Since 2016 Dr. Jian Song has been Priv.-Doz of Experimental Immunology within the Institute of Physiological Chemistry and Pathobiochemsitry at the University of Münster, Germany. He received his PhD of Molecular Medicine from Cologne University, Germany.
Dr. Song's research interests include investigating the role of basement membranes and matrix metalloproteinases in leukocyte extravasation into the brain and into the tumour microenvironment using intravital imaging and scRNA technology
Assistant Professor Departments of Cancer Biology and Genetics and Surgery, The Ohio State University
We are interested in mechanisms of autophagy regulation, with a focus on discovering how to modulate the pathway for optimal therapeutic benefit. Current projects are focused on the identification of novel autophagy regulators and their functional relevance for lung tumorigenesis
I completed my Ph.D dissertation at the University of Zurich, Switzerland where the major focus of my PhD research project was the study of endogenous feline leukemia virus (enFeLV) in cats during exogenous feline leukemia virus (FeLV) infection. My interest in retroviruses led me into the HIV research after Ph.D. My postdoctoral research project at University of California, San Francisco was on HIV immunology. On completion of my Post Doc, I joined Dr Ndhlovu’s new laboratory at the University of Hawaii to pursue studies on HIV and Aging based on my expertise and experience to address a new area of HIV research in which have interest.
Currently my research work as an Assistant Professor at JNU, New Delhi, India is focused on aging in HIV-1-infected people. Approximately one in five individuals living with HIV infection in the United States is 50 years of age or older. This proportion continues to increase as HIV incidence remains stable and potent antiretroviral therapy has reduced the morbidity and mortality associated with HIV infection. However, premature aging and non-AIDS related morbidity including cancer seem to be a new big problem in HAART era. Chronic inflammation in treated HIV-1-infected subjects seems to play an important role in non-AIDS –related complications. The main goal of my research is to investigate the mechanism of HIV mediated accelerated aging/inflammation in HAART-suppressed HIV-1 infected people.
Head of the Institute of Virology, Faculty of Veterinary Medicine, at the Justus-Liebig-Universität Giessen, Germany; Member of the Leopoldina (German Academy of Sciences); Member of two study groups of ICTV (International Committee on Taxonomy of Viruses); Member of Editorial Board for Veterinary Microbiology
Dr. Tripp joined the University of Georgia in 2004 from the Centers of Disease Control and Prevention (CDC) in Atlanta. He is a Professor and Georgia Research Alliance Eminent Scholar working in vaccine and therapeutic studies in the Department of Infectious Diseases at UGA.
Research interests include understanding the mechanisms of immunity and disease pathogenesis associated with respiratory virus infection, and using this information to develop therapeutic protocols and vaccines that will confer long-term protective immunity.
After performing her PhD thesis at the National Institutes of Health (NIH, Bethesda, USA) from 1991 to 1994 and a postdoctoral fellowship in New York from 1994 to 1997, Carine Van Lint joined the Faculty of Sciences of the "Université Libre de Bruxelles" as the head of the Laboratory of Molecular Virology. As a biochemist, Carine Van Lint has developed for the last 25 years a specific interest for pathogenic retroviruses. Her laboratory is mainly studying the role played by epigenetic modifications (such as histone acetylation, histone methylation and DNA methylation) and by non-epigenetic regulatory elements in transcriptional latency and reactivation of HIV-1 (Human Immunodeficiency Virus type 1 - the ethiologic agent of the acquired immunodeficiency syndrome (AIDS)), BLV (Bovine Leukemia Virus - the etiologic agent of a chronic lymphoproliferative disease termed enzootic bovine leucosis) and HTLV-1 (Human T-cell leukemia virus 1 - the etiologic agent of an aggressive lymphoproliferative disease (Adult T-cell Leukemia/Lymphoma) and a neurological degenerative syndrome (tropical spastic paraparesis/HTLV-1-associated myelopathy (TSP/HAM)).
Yegor Vassetzky graduated from the Moscow State University. After a PhD thesis in molecular biology at the Engelhardt Institute of Molecular Biology in Moscow, he worked as a postdoctoral fellow in laboratories of Klaus Scherrer (Paris), Susan Gasser (Lausanne) and Marcel Méchali (Montpellier). Since 2002 he heads the laboratory of Nuclear Organization and Pathologies at Gustave Roussy Institute (Villejuif, France). His main research interests concern epigenetic regulation in cancer and neuromuscular diseases. Yegor Vassetzky is Associate Editor for Biopolymers & Cell, and member of the Editorial Board of PeerJ and Oncotarget.
Dr. Shailendra Kumar Verma is currently a postdoctoral fellow at La Jolla Institute for Immunology, California, USA. He pursued his Ph.D. from Central Drug Research Institute, India in the field of vaccine immunology. Dr. Verma joined DRDE, and had been a scientist since 2005 to 2021. His major research area focused onto the vaccine and therapeutic development against infectious diseases. He has published more than 25 publications in peer reviewed journals of highly repute. Dr. Verma has more than 15 years of research experience in infection and immunology. His present research at La Jolla institute for Immunology is focused onto the vaccine/therapeutic development against SARS-CoV-2 and ZIKA virus.
Full professor, Biological Sciences Department, Los Andes University. Vice dean for Research Affairs, School of Sciences. Past coordinator for the Microbiology program.
Joëlle Wiels received her PhD in Genetics from Université Paris 6-Denis Diderot and then spent two years as a Post-doctoral fellow in the Division of Biochemical Oncology (Fred Hutchinson Cancer Research Center) headed by Professor Hakomori. She then moved back to France where she studied the role of glycosphingolipids in both normal and tumoral B lymphocytes. Since 1991, her main research interests include analysis of apoptotic signaling pathways and of resistance to cell death developped by B cell lymphomas. She is currently affiliated at the METSY CNRS Unit located at the Gustave Roussy Institut in Villejuif (France)
Professor and Department Chair, Department of Integrative Biology, The University of Texas at Austin. Received his PhD in Theoretical Physics from the University of Bochum, Germany, in 1999. Postdoc at Caltech, 2000-2005.
Lead Scientist, Koonin Group at the Computational Biology Branch, National Center for Biotechnology Information, National Library of Medicine, National Institutes of Health (Bethesda, Maryland).